cryptocurrency stock market- Top Overview

In the direction of pan-consumption, there were more than 50 stocks with daily limit, and the concept of big consumption continued to strengthen. Retail, food, home, ice and snow industries and other branches set off a wave of daily limit, and Zhongbai Group, Youhao Group, Huifa Food, Panda Dairy, Wole Home and Meike Home exceeded 50 stocks with daily limit.The European Central Bank cut interest rates by 25 basis points, warning that economic growth will slow down. The European Central Bank cut interest rates by 25 basis points to 3%, and warned that economic growth will be weaker than its previous forecast. This is the fourth time that the European Central Bank has cut interest rates since June, bringing the benchmark interest rate to its lowest level since March 2023. At the same time, the European Central Bank warned that the euro zone economy will only grow by 1.1% in 2025, lower than its forecast of 1.3% in September. It was widely expected that the European Central Bank would cut interest rates. Investors expect that the European Central Bank will cut interest rates more than the Federal Reserve next year, because it is widely expected that the economic growth of the euro zone will lag behind that of the United States. The euro zone's export-dependent economy is also vulnerable to Trump's threat to impose tariffs of up to 20% on all American imports.Polls show that the support rate of Japanese Prime Minister Shi Pomao's cabinet has dropped to 26.8%. According to a report by the Japan News Agency on the 12th local time, the poll conducted by the agency in December showed that the support rate of Shi Pomao's cabinet was 26.8%, down 1.9 percentage points from last month. (CCTV News)

The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.

Russian central bank: Russia's current account surplus in November was $3.2 billion.Guoxuan Hi-Tech: It plans to invest a total of 2.514 billion euros to build new energy battery production bases in Slovakia and Morocco. Guoxuan Hi-Tech announced that the company plans to invest in Slovakia with its own and self-raised funds to build high-performance lithium batteries and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.234 billion euros. On the same day, it was announced that the company plans to invest in Morocco with its own and self-raised funds to build a high-performance lithium battery and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.28 billion euros.COMEX silver fell 1.00% in the day and is now quoted at $32.63 per ounce.